These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 32037948

  • 1. Lymphomas with kidney involvement: the French multicenter retrospective LyKID study.
    Kohn M, Karras A, Zaidan M, Bénière C, de Fréminville JB, Laribi K, Perrin MC, Malphettes M, Le Calloch R, Anglaret B, Martiniuc J, Bailly S, Chevret S, Molina T, Thervet E, Thieblemont C.
    Leuk Lymphoma; 2020 Apr; 61(4):887-895. PubMed ID: 32037948
    [Abstract] [Full Text] [Related]

  • 2. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ, Hu LY, Geng QR, Chen J, Lu ZH, Rao HL, Liu Q, Jiang WQ, Huang HQ, Lin TY, Xia ZJ.
    Chin J Cancer; 2016 Sep 13; 35(1):87. PubMed ID: 27624700
    [Abstract] [Full Text] [Related]

  • 3. [CNS involvement and the feasibility of intratecal chemotherapy administration in patients with a nodal form of diffuse large B-cell lymphoma not otherwise specified. Data of prospective study].
    Magomedova AU, Misyurina AE, Mangasarova JK, Gorenkova LG, Margolin OV, Fastova EA, Kravchenko SK.
    Ter Arkh; 2019 Jul 15; 91(7):35-40. PubMed ID: 32598734
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.
    Guirguis HR, Cheung MC, Mahrous M, Piliotis E, Berinstein N, Imrie KR, Zhang L, Buckstein R.
    Br J Haematol; 2012 Oct 15; 159(1):39-49. PubMed ID: 22849793
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Central nervous system relapse in diffuse large B cell lymphoma: Risk factors].
    Sancho JM, Ribera JM, Working Group on Diagnosis, Prevention and Treatment of CNS Infiltration in Patients with DLBCL.
    Med Clin (Barc); 2016 Jan 15; 146(2):74-80. PubMed ID: 25817451
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Central nervous system prophylaxis in diffuse large B-cell lymphoma.
    Zahid MF, Khan N, Hashmi SK, Kizilbash SH, Barta SK.
    Eur J Haematol; 2016 Aug 15; 97(2):108-20. PubMed ID: 27096423
    [Abstract] [Full Text] [Related]

  • 10. Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone.
    Tomita N, Takasaki H, Ishiyama Y, Kishimoto K, Ishibashi D, Koyama S, Ishii Y, Takahashi H, Numata A, Watanabe R, Tachibana T, Ohshima R, Hagihara M, Hashimoto C, Takemura S, Taguchi J, Fujimaki K, Sakai R, Motomura S, Ishigatsubo Y.
    Leuk Lymphoma; 2015 Mar 15; 56(3):725-9. PubMed ID: 24913502
    [Abstract] [Full Text] [Related]

  • 11. Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study.
    Lemma SA, Pasanen AK, Haapasaari KM, Sippola A, Sormunen R, Soini Y, Jantunen E, Koivunen P, Salokorpi N, Bloigu R, Turpeenniemi-Hujanen T, Kuittinen O.
    Eur J Haematol; 2016 May 15; 96(5):492-501. PubMed ID: 26153511
    [Abstract] [Full Text] [Related]

  • 12. Clinical Effect of CD25 on the Prognosis of Diffuse Large B Cell Lymphoma with Secondary Central Nervous System Relapse.
    Oka S, Ono K, Nohgawa M.
    Pathol Oncol Res; 2020 Jul 15; 26(3):1843-1850. PubMed ID: 31768966
    [Abstract] [Full Text] [Related]

  • 13. Central nervous system relapse in patients with diffuse large B cell lymphoma: analysis of the risk factors and proposal of a new prognostic model.
    Kanemasa Y, Shimoyama T, Sasaki Y, Tamura M, Sawada T, Omuro Y, Hishima T, Maeda Y.
    Ann Hematol; 2016 Oct 15; 95(10):1661-9. PubMed ID: 27370993
    [Abstract] [Full Text] [Related]

  • 14. [Treatment strategy for central nervous system involvement in intravascular large B-cell lymphoma].
    Shimada K.
    Brain Nerve; 2011 May 15; 63(5):467-72. PubMed ID: 21515926
    [Abstract] [Full Text] [Related]

  • 15. Liposomal cytarabine in the prophylaxis and treatment of CNS lymphoma: toxicity analysis in a retrospective case series study conducted at Polish Lymphoma Research Group Centers.
    Jurczak W, Kroll-Balcerzak R, Giebel S, Machaczka M, Giza A, Ogórka T, Fornagiel S, Rybka J, Wróbel T, Kumiega B, Skotnicki AB, Komarnicki M.
    Med Oncol; 2015 Apr 15; 32(4):90. PubMed ID: 25716885
    [Abstract] [Full Text] [Related]

  • 16. Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study.
    Kim SJ, Hong JS, Chang MH, Kim JA, Kwak JY, Kim JS, Yoon DH, Lee WS, Do YR, Kang HJ, Eom HS, Park Y, Won JH, Mun YC, Kim HJ, Kwon JH, Kong JH, Oh SY, Lee S, Bae SH, Yang DH, Jun HJ, Kim YS, Yun HJ, Lee SI, Kim MK, Park EK, Kim WS, Suh C.
    Oncotarget; 2016 Nov 01; 7(44):72033-72043. PubMed ID: 27713132
    [Abstract] [Full Text] [Related]

  • 17. Improved method to stratify lymphoma patients with risk of secondary central nervous system involvement: A multicenter retrospective analysis.
    Lang M, Feng Y, Meng X, Zhao J, Song Z, Qian Z, Qiu L, Zhou S, Liu X, Li L, Yang H, Song Y, Li W, Zhang H.
    Hematol Oncol; 2023 Apr 01; 41(2):239-247. PubMed ID: 34564882
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.